Skip to content
BIO Events
BIG Summit themes: Resilient investment, MFN threat, patients in the center
The inaugural BIO Investment and Growth (BIG) Summit was a chance for leaders in the biotech industry to catch up on domestic and international policy ...
Read More
Latest News
LATEST STORIES
Federal Policy
BIO Coffee Chat: Price controls like MFN harm access, increase costs
“Biotechnology innovation is advancing at an unprecedented pace, delivering new treatments and cures that offer long-awaited hope to patients and their families,” said Karin Hoelzer, ...
International
BIO expert: Future of biotech depends on competing with China, updating FDA
Ensuring a brighter future for U.S. biotech requires modernizing the Food and Drug Administration (FDA) and addressing challenges from China, according to Kelly Seagraves, VP ...
BIO's View
BIO’s comments for USTR report highlight global threats to intellectual property
Strong intellectual property protections sustain biotechnology innovation by enabling the investment needed to develop new medical breakthroughs. In comments submitted for the 2026 U.S. Trade ...
WHAT YOU MISSED AT THE LATEST BIO EVENTS
BIG Summit themes: Resilient investment, MFN threat, patients in the center
The inaugural BIO Investment and Growth (BIG) Summit was a chance for leaders in the biotech industry to catch up on domestic and international policy ...
Read More
BIG Summit panel breaks down risks and opportunities coming out of DC
Washington’s healthcare policy landscape is constantly evolving, and 2026 is shaping up to be another consequential year for the biotech industry. Some developments are positive, ...
Read More